PatentsUSA
Sanofi Advances Legal Battles Over mRNA Patent Rights Against Pfizer and Moderna
Sanofi has launched fresh patent litigation actions against Pfizer and Moderna, focusing on mRNA technology used in COVID-19 vaccines. These legal moves represent new chapters in the complex patent disputes surrounding the development and commercialization of mRNA vaccines, underscoring the competitive and high-stakes…
Wednesday, July 15, 2026